Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1599521

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1599521

Wearable Artificial Kidney Market by Disease Stage (Acute Renal Disease, End-Stage Renal Disease), Dialysis Type (Hemodialysis, Peritoneal Dialysis), End-User - Global Forecast 2025-2030

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Wearable Artificial Kidney Market was valued at USD 180.19 million in 2023, expected to reach USD 213.08 million in 2024, and is projected to grow at a CAGR of 18.74%, to USD 599.78 million by 2030.

The Wearable Artificial Kidney (WAK) is a transformative healthcare innovation designed to provide renal replacement therapy for patients with chronic kidney disease (CKD) outside the traditional clinical settings. This device aims to offer continuous dialysis treatment, enhancing quality of life through greater mobility and flexibility compared to conventional dialysis methods. The necessity of WAKs stems from the growing prevalence of CKD globally, driven by factors such as aging populations, diabetes, and hypertension. Its applications extend beyond life support, potentially reducing complications associated with traditional dialysis, such as infection risks and cardiovascular issues. Key end-use scenarios include home care, outpatient clinics, and remote or underserved areas, providing a significant market scope. The rising public and private healthcare expenditures and advancements in miniaturization and biocompatibility technologies are critical growth factors, helping drive market interest. Emerging opportunities lie in the personalization of treatments, integration with telehealth services, and partnerships with insurance providers to make WAK more accessible. However, limitations include high R&D costs, regulatory challenges, and the need for substantial clinical trials to establish safety and efficacy. Moreover, the high costs of implementation and the complexity of integrating with existing healthcare infrastructure pose challenges. Research innovation should focus on enhancing battery life, reducing size, and improving biocompatibility. Studies on biomaterials and filtration efficiencies are promising areas for pushing technological boundaries. Additionally, exploring AI-driven monitoring systems to provide predictive analytics for personalized patient care could offer competitive advantages. The market nature is dynamic and highly competitive, with an interdisciplinary approach needed to address clinical, technological, and commercial hurdles. Companies should emphasize collaborative ventures with tech firms and clinical entities to optimize product development and expand their market footprint, addressing both technological innovations and regulatory compliance simultaneously.

KEY MARKET STATISTICS
Base Year [2023] USD 180.19 million
Estimated Year [2024] USD 213.08 million
Forecast Year [2030] USD 599.78 million
CAGR (%) 18.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wearable Artificial Kidney Market

The Wearable Artificial Kidney Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of diabetes and hypertension
    • Low presence of donor, leading to limited transplantation
    • Rising awareness about various renal failure diseases, unhealthy lifestyles
  • Market Restraints
    • Stringent regulatory policies for dialysis products
  • Market Opportunities
    • Technological advancement in artificial kidney
    • Increase awareness among patients to opt for ambulatory dialysis
  • Market Challenges
    • Risk of complications of using artificial kidney

Porter's Five Forces: A Strategic Tool for Navigating the Wearable Artificial Kidney Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wearable Artificial Kidney Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wearable Artificial Kidney Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wearable Artificial Kidney Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wearable Artificial Kidney Market

A detailed market share analysis in the Wearable Artificial Kidney Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wearable Artificial Kidney Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wearable Artificial Kidney Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wearable Artificial Kidney Market

A strategic analysis of the Wearable Artificial Kidney Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wearable Artificial Kidney Market, highlighting leading vendors and their innovative profiles. These include ANSELL LTD, Asahi Kasei Medical Co., Ltd., AWAK Technologies, B. Braun, Baxter International Inc., Blood Purification Technologies Inc., Cardinal Health, Inc., Dynarex Corporation, GE Healthcare, Glove Corporation Bhd, Hartalega Holdings, Hitachi Medical Corporation, KAWASUMI LABORATORIES, INC, Koninklijke Philips N.V., Nanodialysis B.V., Semperit AG Holding, Siemens AG, and Triomed AB.

Market Segmentation & Coverage

This research report categorizes the Wearable Artificial Kidney Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Stage, market is studied across Acute Renal Disease and End-Stage Renal Disease.
  • Based on Dialysis Type, market is studied across Hemodialysis and Peritoneal Dialysis.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Dialysis Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-221461476D86

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of diabetes and hypertension
      • 5.1.1.2. Low presence of donor, leading to limited transplantation
      • 5.1.1.3. Rising awareness about various renal failure diseases, unhealthy lifestyles
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory policies for dialysis products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in artificial kidney
      • 5.1.3.2. Increase awareness among patients to opt for ambulatory dialysis
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of complications of using artificial kidney
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wearable Artificial Kidney Market, by Disease Stage

  • 6.1. Introduction
  • 6.2. Acute Renal Disease
  • 6.3. End-Stage Renal Disease

7. Wearable Artificial Kidney Market, by Dialysis Type

  • 7.1. Introduction
  • 7.2. Hemodialysis
  • 7.3. Peritoneal Dialysis

8. Wearable Artificial Kidney Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Dialysis Centers
  • 8.4. Hospitals

9. Americas Wearable Artificial Kidney Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wearable Artificial Kidney Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wearable Artificial Kidney Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ANSELL LTD
  • 2. Asahi Kasei Medical Co., Ltd.
  • 3. AWAK Technologies
  • 4. B. Braun
  • 5. Baxter International Inc.
  • 6. Blood Purification Technologies Inc.
  • 7. Cardinal Health, Inc.
  • 8. Dynarex Corporation
  • 9. GE Healthcare
  • 10. Glove Corporation Bhd
  • 11. Hartalega Holdings
  • 12. Hitachi Medical Corporation
  • 13. KAWASUMI LABORATORIES, INC
  • 14. Koninklijke Philips N.V.
  • 15. Nanodialysis B.V.
  • 16. Semperit AG Holding
  • 17. Siemens AG
  • 18. Triomed AB
Product Code: MRR-221461476D86

LIST OF FIGURES

  • FIGURE 1. WEARABLE ARTIFICIAL KIDNEY MARKET RESEARCH PROCESS
  • FIGURE 2. WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WEARABLE ARTIFICIAL KIDNEY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WEARABLE ARTIFICIAL KIDNEY MARKET DYNAMICS
  • TABLE 7. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY ACUTE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-STAGE RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY DIALYSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM WEARABLE ARTIFICIAL KIDNEY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. WEARABLE ARTIFICIAL KIDNEY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. WEARABLE ARTIFICIAL KIDNEY MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!